AK
Anupam Kumar Pandey
About Anupam Kumar Pandey
Data last updated:
Anupam Kumar Pandey is a Director at Curis Pharma Private Limited (since 2019) and Director at Nosam Labs Private Limited (since 2023). The companies operate in Chemicals and Paper. The largest current company by reported revenue is Curis Pharma Private Limited at ₹33.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jul 2019 | 2019 | ₹33.1 Lakh (FY 2025) | Active | |
| Director | 17 May 2023 | 2023 | Active |
Board colleagues of Anupam Kumar Pandey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bharti Pandey | 09004764 | Curis Pharma Private Limited | Additional Director |
| Nirmala Srivastava | 10167135 | Nosam Labs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anupam Kumar Pandey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anupam Kumar Pandey
Anupam Kumar Pandey currently holds 2 directorships: Curis Pharma Private Limited (Director, since 25 Jul 2019, revenue ₹33.1 Lakh (FY 2025)); Nosam Labs Private Limited (Director, since 17 May 2023).
Anupam Kumar Pandey was first appointed on 25 Jul 2019 as Director at Curis Pharma Private Limited. The most recent appointment on record is 17 May 2023 at Nosam Labs Private Limited.
The current boards of Anupam Kumar Pandey's companies include Bharti Pandey (Curis Pharma Private Limited), Nirmala Srivastava (Nosam Labs Private Limited).